USPTO serial 88337703
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; clinical research; clinical trials; conducting clinical trials for pharmaceutical products; providing information about the results of clinical trials for pharmaceutical products; scientific research for medical purposes in the area of cancerous diseases; research and development services in the fields of oncology, immunology and immuno-oncology | ACTIVE | — |
| 044 | Medical services; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of cancerous diseases; pharmaceutical services; pharmaceutical advisory services; laboratory analysis services relating to the treatment of persons; laboratory analysis services relating to the diagnosis and treatment of cancerous diseases; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncology | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2020 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Nov 5, 2020 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Nov 4, 2020 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Nov 3, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 3, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 3, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 3, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 3, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 3, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 26, 2020 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 19, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 21, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 21, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 21, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 2, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 2, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 16, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Dec 16, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Dec 16, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 22, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 22, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 22, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2019 | NWAP | NEW APPLICATION ENTERED | — |